Open collaboration, non-dilutive funding can nurture more homegrown biotechs
Singapore
THE pandemic has put Singapore biotech research on the global stage, thanks to more open collaboration across the industry.
But biotech startups here could use more funding support, said panellists at the Deep Tech Summit, held in conjunction with the Singapore Week of Innovation & Technology (Switch) 2021.
TRENDING NOW
Grab CEO’s wife Chloe Tong on life with Anthony Tan and finding her purpose
He built the Vingroup empire. Now South-east Asia’s richest man is handing some key roles to his sons
HDB reviewing ‘jumbo’ flat scheme after Telok Blangah unit listed for sale at S$2.18m
What role can Japan play in Asean’s future?